NCT00510419 A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack Status COMPLETED Phase PHASE3
NCT00508950 Study Evaluating Serum Collected From Healthy Adults For Development of Pneumococcal Opsonophagocytic Assay Status COMPLETED Phase NA
NCT00508742 Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization Status COMPLETED Phase PHASE3
NCT00507104 Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH) Status COMPLETED Phase N/A
NCT00507026 Efficacy and Safety of IV Diclofenac (DIV075V)for Pain After Elective Orthopedic Surgery Status COMPLETED Phase PHASE3
NCT00506805 Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies Status COMPLETED Phase PHASE1
NCT00506610 A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak Status WITHDRAWN Phase PHASE2
NCT00505297 A Longitudinal Study of Osteoarthritis (OA) Disease Progression Measured by MRI, dGEMRIC, and Radiography Status COMPLETED Phase N/A
NCT00503529 TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223) Status COMPLETED Phase PHASE4
NCT00503139 Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan Status COMPLETED Phase N/A
NCT00502242 Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus Status COMPLETED Phase PHASE4
NCT00500266 Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects Status COMPLETED Phase PHASE3
NCT00498602 Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00498147 Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program Status UNKNOWN Phase N/A
NCT00496782 Multicenter Pilot Study To Define The Marker As An Alternate For Tropism Assay Status TERMINATED Phase PHASE1
NCT00496769 A Phase III Study of Apixaban in Patients With Atrial Fibrillation Status COMPLETED Phase PHASE3